miR-146 promotes HBV replication and expression by targeting ZEB2.

Area of Science:

• Hepatology
• Molecular Biology
• Virology

Background:

• Hepatitis B virus (HBV) infection causes significant liver disease globally.
• MicroRNAs (miRNAs) play a role in HBV replication, with miR-146a showing a positive correlation.
• The precise regulatory mechanism between miR-146a and HBV replication remains unclear.

Purpose of the Study:

• To elucidate the regulatory relationship between miR-146a and HBV replication.
• To investigate the role of Zinc finger E-box-binding homeobox 2 (ZEB2) in this interaction.
• To explore potential antiviral strategies targeting the miR-146a/ZEB2 pathway.

Main Methods:

• Comparative analysis of miR-146a expression in HepG2.2.15 (HBV-expressing) and HepG2 cells.
• Manipulation of miR-146a and ZEB2 levels (overexpression/downregulation/knockdown) in cell models.
• Assessment of HBV replication and expression following genetic modifications.
• Direct targeting analysis of ZEB2 by miR-146a.
• Evaluation of ZEB2 silencing effects on anti-miR-146a activity.

Main Results:

• miR-146a was upregulated in HBV-expressing cells.
• Overexpression of miR-146a or ZEB2 knockdown enhanced HBV replication.
• Downregulation of miR-146a or ZEB2 overexpression suppressed HBV replication.
• miR-146a was confirmed to directly target ZEB2.
• ZEB2 silencing reversed the inhibitory effect of anti-miR-146a on HBV replication.

Conclusions:

• miR-146a promotes HBV replication and expression by directly targeting ZEB2.
• The miR-146a/ZEB2 axis represents a novel therapeutic target for Hepatitis B virus infection.
• This study provides insights into molecular mechanisms underlying HBV pathogenesis and potential antiviral interventions.